SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

MaxCyte Q3'26 Earnings Preview: EPS Estimated at (0.08) USD

MaxCyte is scheduled to report Q3'26 results on November 10 after the market close. Revenue is estimated at USD 7.39 million, with EPS estimated at (0.08) USD.

MXCT
SquawkNews Desk

MXCT (MaxCyte, Inc.) is set to announce its Q3'26 results on November 10, after the market closes. The earnings are expected to be disclosed at 4:05 PM ET (9:05 PM UTC).For Q3'26, revenue estimate is 7.39 million USD with EPS (earnings per share) anticipated at (0.08) USD. Learn more details at MXC…

Related stories

CorMedix to Acquire Heron Therapeutics Assets for $145 Million and 14.6 Million Shares CorMedix agreed to acquire substantially all of Heron Therapeutics’ assets for $145 million in cash, subject to adjustments, and 14,583,333 CorMedix shares. The deal also includes M impact | EQUITY | Nov 09, 2026, 01:04 PM UTC Al Manar Financing and Leasing Q3 Profit 975,834 Dinars M impact | EQUITY | Nov 09, 2026, 12:56 PM UTC RadNet Reports Q3 Revenue of $638.3 Million, Raises 2026 Guidance Third-quarter 2026 revenue rose 22.1% year over year to $638.3 million, and Adjusted EBITDA increased 23.8% to $105.0 million. Net income attributable to common stockholders was $4 M impact | EQUITY | Nov 09, 2026, 12:53 PM UTC Bicara Reports Q3 2026 Net Loss of $71.2 Million Bicara reported a net loss of $71.2 million for the third quarter of 2026, versus $36.3 million a year earlier. It had $442.3 million in cash, cash equivalents and marketable secur M impact | EQUITY | Nov 09, 2026, 12:53 PM UTC Goodyear CEO Mark Stewart Steps Down Goodyear said Stewart stepped down as CEO, president and board member with immediate effect. Director Roger Wood has been appointed. M impact | EQUITY | Nov 09, 2026, 12:51 PM UTC Baazeem reports Q3 profit of SAR 6.76927 million M impact | EQUITY | Nov 09, 2026, 12:51 PM UTC